Centre For Clinical Research And Biostatistics (CCRB)

Back

1 Unique Trial Number (assigned by CCRB)

CUHK_CCRB00637

2 Trial Registration Date

2018-11-27

i Registration Status

Prospective

3 Secondary IDs

/

4 Source(s) of Funding

/

5 Primary Sponsor

/

6 Secondary Sponsor

/

Function

Not Applicable

Please specify

7 Responsible Contact Person (public contact person for patients interested in participating)

i Name

Huen Yan Chan

ii Address

RM 2912, 29/F, Yan Tin Hse, Hing Tin Est, Lam Tin, Kowloon, HK

iii Phone

93329340

iv Email

ansonchanhuenyan@yahoo.com.hk

v Affiliation

Faculty of Medicine, Faculty of Medicine

vi Country

Hong Kong, China

8 Research Contact Person (person to contact for scientific inquiries)

i Name

Huen Yan Chan

ii Address

RM 2912, 29/F, Yan Tin Hse, Hing Tin Est, Lam Tin, Kowloon, HK

iii Phone

9332 9340

iv Email

ansonchanhuenyan@yahoo.com.hk

v Affiliation

Faculty of Medicine, Faculty of Medicine

vi Country

Hong Kong, China

9 Official Scientific Title of the Study

“Design Thinking in the Development of Integrative Medicine Healthcare Model: An Exploration of the Feasibility of Implementing a Patient Checklist in Medicine Outpatient Clinic”

10 Public Title

“Design Thinking in the Development of Integrative Medicine Healthcare Model: An Exploration of the Feasibility of Implementing a Patient Checklist in Medicine Outpatient Clinic”

i Public Title in Chinese 研究名稱

門診病人參考清單調查

11 Short Title (Optional)

12 Countries of Recruitment

Hong Kong, China

13 Research Ethic Review

i Has the study received appropriate ethics approval?

Yes

ii When is the approval date?

2018-11-08

iii Full Name of IRB/IEC

Joint CUHK-NTEC Clinical Research Ethics Committee

Please specify

iv IRB/IEC approval reference number

2018.296

14 Medical Condition Being Studied

Patients in medicine outpatient clinic follow up consultations. No diseases specification.

15 Intervention

i Types of intervention

Other

Please specify

/

ii Description/ name of Intervention/article

/

iii Dosage form of the intervention

/

iv Dosage of the intervention

/

v Duration of the intervention

/

vi Frequency of the intervention

/

16 Comparative Treatments

i Description/ name of comparative treatments

/

ii Dosage form of the comparative treatments

/

iii Dosage of the comparative treatments

/

iv Duration of the comparative treatments

/

v Frequency of the comparative treatments

/

17 Key Inclusion and Exclusion Criteria

i Inclusion Criteria

For patient focus group, the inclusion criteria includes: 1. HK citizens with the HK Identity Card

Aged 18 or above on the date of attendance

Able to listen and speak Cantonese

Able to understand the interview (as judged by the interviewer)

Able to give informed consent.

For doctor focus group, junior doctors (5 years within graduation)

Whose job includes consultation of old cases in LKS medical outpatient clinic

ii Exclusion Criteria

/

iii Age Minimum

18

iv Age Maximum

999

v Gender

Both Male and Female

18 Study Type

Observational

19 Study Design

i Randomization

Not Applicable

Please specify

ii Nature of control

Not Applicable

iii Degree of masking

Not Applicable

If Single-blind, who will be masked?

iv Group Assignment

Not Applicable

v Study Phase

Other

Please specify

not applicable

vi Study Objectives (Optional)

20 Anticipated trial start date

2018-12-17

21 Target Sample Size

18-35

22 Recruitment Status

Not Yet Recruiting

23 Primary Outcome

i The Name of the outcome

Idea frequencies and common ideas proposed during focus groups interview. and its implications would be considered. A summative content analysis involves counting and comparisons, usually of keywords or content raised during data collectio

ii The metric or method of measurement used

Data collected from focus group discussion/ individual interviews will be transcribed verbatim and input into NVivo software for data management and analysis

iii The timepoint(s) of primary interest

/

24 Secondary Outcome

i The Name of the outcome

/

ii The metric or method of measurement used

/

iii The timepoint(s) of primary interest

/

25 Study Information/Publication

i Study Information/Publication Available?

No

ii Link to Study Information/Publication

26 Last Update Date

2019-01-29

27 Primary Registry and Trial Identifying Number

28 Date of Registration in Primary Registry

Back

Trial History Detail on 2018-11-27